PODD Q1 2026 Earnings Strong EPS Beat Overshadowed by Tepid Market Response AGNCZ Q1 2026 Earnings EPS Surpasses Estimates with 145 Beat Preferred Shares Edge Higher GIGM Q3 2025 Earnings Narrowed Losses Amid Strategic Restructuring QURE Q1 2026 Earnings NarrowerthanExpected Loss Amid Gene Therapy Pipeline Progress WCN Q1 2026 Earnings Waste Connections Beats EPS Estimates Amid Quiet Market Reaction CSAN Q1 2026 Earnings Heavy Losses as EPS Misses Estimates by a Wide Margin